Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
RITUXIMAB | Device related sepsis | 4 |
RITUXIMAB | Disease recurrence | 4 |
Rituximab | Disseminated intravascular coagulation | 4 |
RITUXIMAB | Drug effect decreased | 4 |
Rituximab | Escherichia bacteraemia | 4 |
Rituximab | Eye pain | 4 |
Rituximab | Flushing | 4 |
RITUXIMAB | Gastric haemorrhage | 4 |
RITUXIMAB | H1N1 influenza | 4 |
RITUXIMAB | Haemoglobin decreased | 4 |
RITUXIMAB | Hepatocellular carcinoma | 4 |
Rituximab | Hyperbilirubinaemia | 4 |
RITUXIMAB | Hyperglycaemia | 4 |
RITUXIMAB | Hyperreflexia | 4 |
Rituximab | Infectious colitis | 4 |
RITUXIMAB | Invasive lobular breast carcinoma | 4 |
Rituximab | Lentigo | 4 |
RITUXIMAB | Leukocytosis | 4 |
Rituximab | Liver function test abnormal | 4 |
Rituximab | Lymphoedema | 4 |
Total Records: 1,104 Number of Pages: 56